Profile data is unavailable for this security.
About the company
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
- Revenue in USD (TTM)36.68m
- Net income in USD-36.78m
- Incorporated2019
- Employees210.00
- LocationAlpha Teknova Inc2451 Bert DriveHOLLISTER 95023United StatesUSA
- Phone+1 (831) 637-1100
- Fax+1 (845) 818-3588
- Websitehttps://www.teknova.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics Inc | 34.70m | -233.11m | 72.68m | 173.00 | -- | -- | -- | 2.09 | -2.12 | -2.12 | 0.3016 | -0.817 | 0.1485 | 0.9947 | 1.92 | 154,240.00 | -99.76 | -70.20 | -213.09 | -86.94 | 69.30 | -- | -671.70 | -1,559.33 | 0.50 | -- | -- | -- | -86.51 | -- | -20.95 | -- | -49.14 | -- |
Curis Inc | 9.81m | -47.73m | 74.27m | 48.00 | -- | 7.85 | -- | 7.57 | -8.68 | -8.68 | 1.77 | 1.61 | 0.1253 | -- | 4.39 | 204,416.70 | -60.97 | -37.25 | -69.58 | -41.12 | 97.60 | 96.05 | -486.45 | -409.44 | -- | -- | 0.00 | -- | -1.37 | -0.7891 | 16.34 | -- | -- | -- |
CEL-SCI Corp | 0.00 | -29.95m | 75.57m | 43.00 | -- | 5.29 | -- | -- | -0.6304 | -0.6304 | 0.00 | 0.2645 | 0.00 | -- | -- | -- | -87.78 | -70.19 | -103.56 | -78.31 | -- | -- | -- | -15,434.15 | 1.18 | -39.26 | 0.4319 | -- | -- | -- | 13.99 | -- | 223.59 | -- |
Instil Bio Inc | 0.00 | -123.32m | 76.75m | 49.00 | -- | 0.3729 | -- | -- | -18.96 | -18.96 | 0.00 | 31.65 | 0.00 | -- | -- | 0.00 | -33.63 | -- | -35.47 | -- | -- | -- | -- | -- | -- | -- | 0.2841 | -- | -- | -- | 30.06 | -- | -- | -- |
Protara Therapeutics Inc | 0.00 | -42.47m | 77.01m | 26.00 | -- | 0.7322 | -- | -- | -3.74 | -3.74 | 0.00 | 5.11 | 0.00 | -- | -- | 0.00 | -48.67 | -37.02 | -52.23 | -38.29 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 38.71 | -- | -17.67 | -- |
Rallybio Corp | 0.00 | -76.28m | 77.10m | 43.00 | -- | 0.7888 | -- | -- | -1.88 | -1.88 | 0.00 | 2.36 | 0.00 | -- | -- | 0.00 | -58.30 | -- | -62.32 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.87 | -- | -- | -- |
Alpha Teknova Inc | 36.68m | -36.78m | 77.56m | 210.00 | -- | 0.8609 | -- | 2.11 | -1.17 | -1.17 | 1.15 | 2.21 | 0.2612 | 2.21 | 8.94 | 174,685.70 | -26.19 | -- | -28.17 | -- | 28.07 | -- | -100.26 | -- | 3.84 | -37.45 | 0.1283 | -- | -11.43 | -- | 22.52 | -- | -- | -- |
Cognition Therapeutics Inc | 0.00 | -28.77m | 77.71m | 25.00 | -- | 2.69 | -- | -- | -0.9155 | -0.9155 | 0.00 | 0.7218 | 0.00 | -- | -- | 0.00 | -68.08 | -- | -85.18 | -- | -- | -- | -- | -- | -- | -251.59 | 0.00 | -- | -- | -- | -20.52 | -- | -- | -- |
MDxHealth SA - ADR | 75.33m | -39.90m | 78.04m | 300.00 | -- | -- | -- | 1.04 | -1.14 | -1.14 | 0.8428 | -0.0357 | 0.5528 | 11.06 | 6.95 | 251,090.00 | -29.28 | -51.62 | -33.98 | -64.72 | 62.76 | 50.88 | -52.97 | -117.64 | 1.53 | -1.71 | 1.02 | -- | 89.43 | 19.84 | 2.14 | -- | 30.13 | -- |
Elutia Inc | 25.05m | -49.46m | 78.41m | 54.00 | -- | -- | -- | 3.13 | -2.35 | -2.34 | 1.24 | -2.07 | 0.5219 | 2.06 | 4.27 | 463,833.30 | -103.05 | -42.93 | -599.50 | -79.34 | 42.01 | 43.32 | -197.48 | -64.16 | 0.5499 | -1.36 | -- | -- | -49.69 | -8.71 | -25.39 | -- | 12.74 | -- |
BioXcel Therapeutics Inc | 1.76m | -153.05m | 78.44m | 74.00 | -- | -- | -- | 44.67 | -5.18 | -5.18 | 0.0591 | -2.15 | 0.0134 | 0.6067 | 5.31 | 23,729.73 | -116.64 | -74.57 | -151.39 | -84.06 | 24.15 | -- | -8,715.72 | -32,300.74 | 2.49 | -15.67 | 3.47 | -- | 268.00 | -- | -8.02 | -- | -43.26 | -- |
Gritstone bio Inc | 15.65m | -144.89m | 81.06m | 231.00 | -- | 5.25 | -- | 5.18 | -1.57 | -1.57 | 0.17 | 0.1423 | 0.0901 | -- | 40.53 | 67,727.27 | -83.47 | -48.08 | -97.70 | -55.18 | -- | -- | -926.13 | -573.71 | -- | -554.88 | 0.7428 | -- | -18.05 | 68.96 | -15.71 | -- | -4.19 | -- |
Assembly Biosciences Inc | 12.95m | -51.36m | 81.16m | 65.00 | -- | 2.48 | -- | 6.27 | -11.22 | -11.22 | 2.76 | 5.95 | 0.1276 | -- | 34.07 | 199,200.00 | -50.60 | -39.69 | -66.58 | -44.03 | -- | -- | -396.63 | -409.24 | -- | -- | 0.00 | -- | -- | -13.51 | 34.23 | -- | -5.59 | -- |
Aileron Therapeutics Inc | 0.00 | -15.73m | 81.40m | 15.00 | -- | 2.73 | -- | -- | -3.39 | -3.39 | 0.00 | 20.12 | 0.00 | -- | -- | 0.00 | -24.58 | -65.99 | -26.17 | -75.37 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 42.43 | -- | -- | -- |
Provectus Biopharmaceuticals Inc | 557.71k | -3.10m | 81.47m | 4.00 | -- | -- | -- | 146.08 | -0.0074 | -0.0074 | 0.0013 | -0.0181 | 0.32 | -- | 1,282.09 | 139,427.50 | -177.95 | -276.33 | -- | -- | -- | -- | -556.16 | -1,667.76 | -- | -13.22 | -- | -- | -43.61 | -- | 12.74 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Millennium Management LLCas of 31 Dec 2023 | 1.81m | 4.44% |
Balyasny Asset Management LPas of 31 Dec 2023 | 1.05m | 2.56% |
Platinum Investment Management Ltd.as of 31 Dec 2023 | 736.54k | 1.81% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 393.44k | 0.96% |
Parkman Healthcare Partners LLCas of 31 Dec 2023 | 282.24k | 0.69% |
Conestoga Capital Advisors LLCas of 31 Mar 2024 | 249.95k | 0.61% |
Bank of America, NA (Private Banking)as of 31 Dec 2023 | 216.22k | 0.53% |
Redmile Group LLCas of 31 Dec 2023 | 161.01k | 0.40% |
Geode Capital Management LLCas of 31 Dec 2023 | 145.88k | 0.36% |
Morgan Stanley & Co. LLCas of 31 Dec 2023 | 103.28k | 0.25% |